- Home
- PAPL vs BFRI Comparison
PAPL vs BFRI Comparison
Compare PAPL & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAPL
- BFRI
- Stock Information
- Founded
- PAPL 2015
- BFRI 1997
- Country
- PAPL Canada
- BFRI United States
- Employees
- PAPL N/A
- BFRI N/A
- Industry
- PAPL Finance: Consumer Services
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- PAPL Finance
- BFRI Health Care
- Exchange
- PAPL Nasdaq
- BFRI Nasdaq
- Market Cap
- PAPL 5.8M
- BFRI 6.2M
- IPO Year
- PAPL 2023
- BFRI 2021
- Fundamental
- Price
- PAPL $0.43
- BFRI $0.87
- Analyst Decision
- PAPL Strong Buy
- BFRI Strong Buy
- Analyst Count
- PAPL 1
- BFRI 1
- Target Price
- PAPL $5.50
- BFRI $7.00
- AVG Volume (30 Days)
- PAPL 105.8K
- BFRI 7.3M
- Earning Date
- PAPL 01-14-2025
- BFRI 11-13-2024
- Dividend Yield
- PAPL N/A
- BFRI N/A
- EPS Growth
- PAPL N/A
- BFRI N/A
- EPS
- PAPL N/A
- BFRI N/A
- Revenue
- PAPL $2,535,718.00
- BFRI $35,358,000.00
- Revenue This Year
- PAPL $38.59
- BFRI $19.11
- Revenue Next Year
- PAPL $61.76
- BFRI $20.16
- P/E Ratio
- PAPL N/A
- BFRI N/A
- Revenue Growth
- PAPL N/A
- BFRI 5.17
- 52 Week Low
- PAPL $0.43
- BFRI $0.61
- 52 Week High
- PAPL $3.97
- BFRI $4.04
- Technical
- Relative Strength Index (RSI)
- PAPL 30.38
- BFRI 49.94
- Support Level
- PAPL $0.46
- BFRI $0.65
- Resistance Level
- PAPL $0.55
- BFRI $0.79
- Average True Range (ATR)
- PAPL 0.07
- BFRI 0.11
- MACD
- PAPL -0.02
- BFRI -0.00
- Stochastic Oscillator
- PAPL 1.36
- BFRI 53.55
About PAPL Pineapple Financial Inc.
Pineapple Financial Inc is a Canada-based mortgage technology and brokerage company that provides mortgage brokerage services and technology solutions to Canadian mortgage agents, brokers, sub-brokers, brokerages, and consumers. Through its data-driven systems together with cloud-based tools, it offers advantages in the Canadian mortgage industry relative to alternative mortgage broker arrangements and also provides back office services.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.